Competitor
Technology
Target Offering
Competitive Disadvantage
Re-Generox Advantage
Retin-A, LaserResurfacing
Chemical or laser-based Treatments
Anti-aging skin treatment
Limited to topical or surface level results, requires continuous usage
Novel Mixture IP
(Delivers mRNA directly into skin cells for longer-lasting, deeper rejuvenation.)
Botox, Muscle-Paralyzing agents
(Botox, Dysport, Xeomin, etc.)
Injectable muscle-paralyzing Solutions
Anti-wrinkle, muscle relaxing treatment
Short-term results, requires regular injections
Skin Penetration Metnod IP
Minimally invasive approach, delivering lasting rejunvenation without paralysis
Surgical Cosmetic Procedures
(Facelifts, browlifts, etc.)
Invasive Surgical Procedures
Facial enhancement, tightening, and rejuvenation
High-costinvasive, longer recovery period
Cost-effective, non-invasive alternative
Long-lasting effects without surgery
L’oreal, Estee Lauder, Shiseido
(Indirect Competitors.)
Traditional Skincare Procedures
Premium skincare for general skin health
Limited to over-the-counter products, slower results
Scientifically backed
mRNA-driven solutions with deeper penetration and longer-lasting, visible results.
Aspirational Competitors
(Moderna, BioNTech, Pfizer.)
mRNA-based therapeutics
(Pharma focus.)
Potential to enter cosmetic space with advanced mRNA applications
Potential to enter cosmetic space with advanced mRNA applications
Pioneering cosmetic mRNA solutions
First to market with cosmetic focused mRNA therapeutics
